Terms: = Breast cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Treatment
523 results:
1. Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative breast cancer.
Fan T; Huang Y; Liu Z; Huang J; Ke B; Rong Y; Qiu H; Zhang B
Drug Des Devel Ther; 2024; 18():1115-1131. PubMed ID: 38618280
[TBL] [Abstract] [Full Text] [Related]
2. Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study.
Xu Y; Yang J; Han X; Gan C; Wei X
Medicine (Baltimore); 2024 Apr; 103(15):e37829. PubMed ID: 38608062
[TBL] [Abstract] [Full Text] [Related]
3. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
4. Drug-resilient cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation.
Carroll C; Manaprasertsak A; Boffelli Castro A; van den Bos H; Spierings DCJ; Wardenaar R; Bukkuri A; Engström N; Baratchart E; Yang M; Biloglav A; Cornwallis CK; Johansson B; Hagerling C; Arsenian-Henriksson M; Paulsson K; Amend SR; Mohlin S; Foijer F; McIntyre A; Pienta KJ; Hammarlund EU
Cancer Res Commun; 2024 Mar; 4(3):691-705. PubMed ID: 38385626
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of ATM promotes PD-L1 expression by activating JNK/c-jun/TNF-α signaling axis in triple-negative breast cancer.
Liu C; Qian X; Yu C; Xia X; Li J; Li Y; Xie Y; Gao G; Song Y; Zhang M; Xue H; Wang X; Sun H; Liu J; Deng W; Guo X
Cancer Lett; 2024 Apr; 586():216642. PubMed ID: 38278470
[TBL] [Abstract] [Full Text] [Related]
6. Homeobox Protein PROX1 Expression is Negatively Regulated by Histone Deacetylase 1 and c-jun Complex in MDA-MB-231 Human breast cancer Cells.
Jeong M; Jung E; Oh S; Shin SY
Folia Biol (Praha); 2023; 69(3):81-90. PubMed ID: 38206773
[TBL] [Abstract] [Full Text] [Related]
7. Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway.
Tao J; Xue C; Cao M; Ye J; Sun Y; Chen H; Guan Y; Zhang W; Zhang W; Yao Y
Breast Cancer Res; 2024 Jan; 26(1):1. PubMed ID: 38167446
[TBL] [Abstract] [Full Text] [Related]
8. Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer.
Saatci O; Cetin M; Uner M; Tokat UM; Chatzistamou I; Ersan PG; Montaudon E; Akyol A; Aksoy S; Uner A; Marangoni E; Sajish M; Sahin O
Nat Commun; 2023 Nov; 14(1):6997. PubMed ID: 37914699
[TBL] [Abstract] [Full Text] [Related]
9. Architecture and topologies of gene regulatory networks associated with breast cancer, adjacent normal, and normal tissues.
Kumar S; Vindal V
Funct Integr Genomics; 2023 Oct; 23(4):324. PubMed ID: 37878223
[TBL] [Abstract] [Full Text] [Related]
10. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
11. CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis.
Behrouzi R; Armstrong AC; Howell SJ
Breast Cancer Res Treat; 2023 Nov; 202(1):83-95. PubMed ID: 37584881
[TBL] [Abstract] [Full Text] [Related]
12. Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
Lee MG; Lee KS; Nam KS
IUBMB Life; 2023 Sep; 75(9):765-777. PubMed ID: 37492896
[TBL] [Abstract] [Full Text] [Related]
13. The Role of FBXW7 in Gynecologic Malignancies.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
Cells; 2023 May; 12(10):. PubMed ID: 37408248
[TBL] [Abstract] [Full Text] [Related]
14. P2Y
Jin H; Ko YS; Yun SP; Park SW; Kim HJ
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37165911
[TBL] [Abstract] [Full Text] [Related]
15. IL11 signaling mediates piR-2158 suppression of cell stemness and angiogenesis in breast cancer.
Zhao Q; Qian L; Guo Y; Lü J; Li D; Xie H; Wang Q; Ma W; Liu P; Liu Y; Wang T; Wu X; Han J; Yu Z
Theranostics; 2023; 13(7):2337-2349. PubMed ID: 37153732
[TBL] [Abstract] [Full Text] [Related]
16. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/Yap1/c-jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
17. MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.
Katzengruber L; Sander P; Laufer S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108658
[TBL] [Abstract] [Full Text] [Related]
18. Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway.
Hao XS; Feng PP; Zhang YY; Wang FZ; Wang GL; Fei HR
Chem Biol Interact; 2023 Jun; 378():110487. PubMed ID: 37072049
[TBL] [Abstract] [Full Text] [Related]
19. 18β-glycyrrhetinic Acid Modulated Autophagy is Cytotoxic to breast cancer Cells.
Hsu YC; Hsieh WC; Chen SH; Li YZ; Liao HF; Lin MY; Sheu SM
Int J Med Sci; 2023; 20(4):444-454. PubMed ID: 37057216
[TBL] [Abstract] [Full Text] [Related]
20. Icariin Induces Triple-Negative breast cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-jun Signaling Pathway.
Gao S; Zhang X; Liu J; Ji F; Zhang Z; Meng Q; Zhang Q; Han X; Wu H; Yin Y; Lv Y; Shi W
Drug Des Devel Ther; 2023; 17():821-836. PubMed ID: 36969705
[TBL] [Abstract] [Full Text] [Related]
[Next]